4.5 Article

SMALL RANDOMIZED TRIAL AMONG LOW-BIRTH-WEIGHT CHILDREN RECEIVING BACILLUS CALMETTE-GUERIN VACCINATION AT FIRST HEALTH CENTER CONTACT

Journal

PEDIATRIC INFECTIOUS DISEASE JOURNAL
Volume 31, Issue 3, Pages 306-308

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/INF.0b013e3182458289

Keywords

BCG; infant mortality; neonatal mortality; nonspecific effects of vaccines

Funding

  1. EU [ICA4-CT-2002-10053]
  2. March of Dimes
  3. Danish National Research Foundation
  4. European Research Council (ERC) [243149]
  5. DANIDA
  6. Novo Nordisk Foundation

Ask authors/readers for more resources

A total of 105 low-birth-weight children presenting for first vaccination were randomized to receive bacillus Calmette-Guerin (BCG) immediately or later (current practice). The mortality rate ratio for BCG was 0.17 (95% CI = 0.02-1.35) within 3 days of enrollment, 0.28 (0.06-1.37) in the first month, and 0.27 (0.07-0.98) after 2 months of age. The mortality rate ratio was 0.41 (0.14-1.18) (P = 0.098) in infancy. Administration of BCG vaccine at first contact may contribute to lower mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available